Abstract
Because of the biophysical relation between muscle fibre diameter and the propagation velocity of action potentials along the muscle fibres, motor unit conduction velocity (MUCV) could be a non-invasive index of muscle fibre size in humans. However, the relation between MUCV and fibre size has been only assessed indirectly in animal models and in human patients with invasive intramuscular EMG recordings, or it has been mathematically derived from computer simulations. By combining advanced non-invasive techniques to record motor unit activity in vivo, i.e., high-density surface EMG, with the gold standard technique for muscle tissue sampling, i.e., muscle biopsy, here we investigated the relation between the conduction velocity of populations of motor units identified from the biceps brachii muscle, and muscle fibre diameter. Moreover, we demonstrate the possibility to predict muscle fibre diameter ($R^2 = 0.66$) and cross-sectional area ($R^2 = 0.65$) from conduction velocity estimates with low systematic bias (~2% and ~4% respectively) and a relatively low margin of individual error (~8% and ~16%, respectively). The proposed neuromuscular interface opens new perspectives in the use of high-density EMG as a non-invasive tool to estimate muscle fibre size without the need of surgical biopsy sampling.
Introduction
In clinical and sports science, monitoring muscle fiber morphology is essential for tracking aging, disease progression, or training adaptations. Traditionally, the "gold standard" for this assessment is a muscle biopsy—an invasive procedure requiring a large needle to extract tissue. While effective, it is painful, carries infection risks, and provides only a localized sample. Researchers have long hypothesized that larger muscle fibers conduct electrical signals faster, but validating this non-invasively in humans has been challenging. This study introduces a neuromuscular interface that uses high-density surface electromyography (HDsEMG) to accurately predict muscle fiber size without surgery.
Methods
The study involved 29 healthy men, including both resistance-trained and untrained individuals, to capture a wide range of fiber sizes. The experimental workflow integrated two primary techniques:
- HDsEMG and Signal Decomposition: Two grids of 64 electrodes were placed over the biceps brachii. Advanced "blind source separation" algorithms (Convolution Kernel Compensation) decomposed the surface signals into the activity of 701 unique motor units.
- Motor Unit Conduction Velocity (MUCV): Action potential propagation speed was calculated using a multi-channel maximum likelihood algorithm.
- Biopsy Validation: To establish "ground truth," biopsies were performed in the same muscle region. Over 5,600 fibers were analyzed microscopically for cross-sectional area (CSA) and diameter (MFD).
- The Interface: A linear transformation mapped electrical velocity (MUCV) to physical size (MFD) based on established biophysical equations.
Key Results and Insights
The non-invasive interface demonstrated high predictive accuracy compared to the biopsy standard. The model predicted mean fiber diameter with an $R^2 = 0.66$ and cross-sectional area with an $R^2 = 0.65$. Systematic bias was remarkably low (~2% for diameter), and individual error margins (~8% for diameter) were comparable to the inherent variability of physical biopsies.
Several key insights emerged from the data:
- Biophysical Correlation: The results confirmed that larger fibers exhibit lower cytoplasmic resistance, leading to faster action potential propagation.
- Robustness to Subcutaneous Fat: Surprisingly, MUCV was not significantly influenced by the thickness of the fat layer between muscle and skin. This suggests the tool is robust across diverse body types.
- Size Principle: High-threshold motor units (recruited for heavy loads) consisted of larger fibers and showed significantly faster conduction velocities, reinforcing the physiological size principle.
- Generalizability: Leave-one-out cross-validation indicated the model could predict fiber size for new subjects using general calibration, potentially eliminating the need for individual biopsy-based calibration.
Discussion and Future Perspectives
While the tool excels at predicting average fiber size for a muscle population, it cannot yet determine the size of specific individual fibers. Additionally, because biopsies sample only a tiny fraction of the muscle, HDsEMG might actually offer a more representative view of the whole muscle's morphology.
Future research should expand this interface to different muscle groups and clinical populations, such as those with sarcopenia or muscular dystrophy, to determine if these linear relationships hold in diseased or aged tissue. This non-invasive approach offers a painless alternative for monitoring muscle health in aging, space flight, and exercise physiology.
Summary updated